Nanjing, China

Ping Xu


 

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 25(Granted Patents)


Location History:

  • Nanjing, CN (2012 - 2016)
  • Jiangsu, CN (2022)

Company Filing History:


Years Active: 2012-2022

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: The Innovations of Ping Xu

Introduction

Ping Xu is a notable inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceuticals and photonics, holding a total of four patents. His work focuses on innovative solutions for cancer treatment and advanced photonic technologies.

Latest Patents

One of his latest patents is a quinoline derivative for the treatment of nasopharyngeal carcinoma. This invention provides a quinoline derivative that can be utilized in the preparation of a pharmaceutical composition aimed at tumor treatment. Another significant patent involves on-chip path-entangled photonic sources based on periodical poling and waveguide circuits in ferroelectric crystals. This photonic chip integrates waveguide circuits, periodical poling, and electro-optic modulators to guide photons and perform linear operations such as beam splitting and filtering. The efficient spontaneous parametric down conversion (SPDC) enabled by periodical poling results in the generation of entangled photons, which can be dynamically controlled.

Career Highlights

Throughout his career, Ping Xu has worked with prominent organizations, including Chevron (HK) Limited and Nanjing University. His experience in these institutions has contributed to his expertise in both the pharmaceutical and photonic fields.

Collaborations

He has collaborated with notable individuals such as Mitch Mulder and Hua Jin, further enhancing his innovative projects and research.

Conclusion

Ping Xu's contributions to the fields of pharmaceuticals and photonics demonstrate his commitment to innovation and advancement. His patents reflect a deep understanding of complex scientific principles and a dedication to improving treatment options for serious health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…